Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
The latest update is out from Vita Life Sciences Limited ( (AU:VLS) ).
Vita Life Sciences Limited has announced a change in the director’s interest as Peter Osborne has acquired 4,820 ordinary shares in the company through an on-market trade. This acquisition increases Osborne’s total holdings to 30,094 shares, reflecting a potential increase in confidence and commitment from the director towards the company’s future prospects.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, offering a range of pharmaceutical and nutraceutical products. The company is focused on providing health solutions and enhancing well-being through its diverse product offerings.
YTD Price Performance: -19.00%
Average Trading Volume: 18,617
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$90.13M
Learn more about VLS stock on TipRanks’ Stock Analysis page.